Age-related changes in neuroactive steroid levels in 3xTg-AD mice

Neurobiology of Aging

Volumn 34, Issue 4, 2013, Pages 1080-1089

  Caruso, Donatella ^a   Barron, Anna M ^b,c   Brown, Meghan A ^b   Abbiati, Federico ^a   Carrero, Paloma ^d   Pike, Christian J ^b   Garcia Segura, Luis M ^d   Melcangi, Roberto C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d INSTITUTO CAJAL   (Spain)

Author keywords

Alzheimer's disease; GABA A receptors; Limbic region; Metabolic pathways; Progesterone; Testosterone

Indexed keywords

17ALPHA ESTRADIOL; 20ALPHA DIHYDROPROGESTERONE; 3BETA ANDROSTANEDIOL; 4 AMINOBUTYRIC ACID A RECEPTOR; AMYLOID BETA PROTEIN; ANDROSTANEDIOL; ANDROSTANOLONE; ESTRADIOL; PRASTERONE; PREGNENOLONE; PROGESTERONE; SEPRANOLONE; STEROID; TESTOSTERONE; TETRAHYDROPROGESTERONE;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GLIOSIS; IMMUNOHISTOCHEMISTRY; LIMBIC CORTEX; MALE; METABOLITE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SIGNAL TRANSDUCTION; STEROID BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; ANIMALS; LIMBIC SYSTEM; MICE; MICE, TRANSGENIC; RECEPTORS, STEROID; STEROIDS; TISSUE DISTRIBUTION;

EID: 84872318571     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.10.007     Document Type: Article

References (52)

1. Arevalo M.A., Santos-Galindo M., Bellini M.J., Azcoitia I., Garcia-Segura L.M. Actions of estrogens on glial cells: implications for neuroprotection. Biochim. Biophys. Acta 2010, 1800:1106-1112.
2. Azcoitia I., Sierra A., Veiga S., Honda S., Harada N., Garcia-Segura L.M. Brain aromatase is neuroprotective. J. Neurobiol. 2001, 47:318-329.
3. Barreto G., Santos-Galindo M., Diz-Chaves Y., Pernia O., Carrero P., Azcoitia I., Garcia-Segura L.M. Selective estrogen receptor modulators decrease reactive astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones. Endocrinology 2009, 150:5010-5015.
4. Barreto G., Veiga S., Azcoitia I., Garcia-Segura L.M., Garcia-Ovejero D. Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. Eur. J. Neurosci. 2007, 25:3039-3046.
5. Birzniece V., Backstrom T., Johansson I.M., Lindblad C., Lundgren P., Lofgren M., Olsson T., Ragagnin G., Taube M., Turkmen S., Wahlstrom G., Wang M.D., Wihlback A.C., Zhu D. Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res. Rev. 2006, 51:212-239.
6. Bitran D., Hilvers R.J., Kellogg C.K. Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res. 1991, 561:157-161.
7. Bittner T., Fuhrmann M., Burgold S., Ochs S.M., Hoffmann N., Mitteregger G., Kretzschmar H., LaFerla F.M., Herms J. Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PLoS One 2010, 5:e15477.
8. Brinton R.D., Thompson R.F., Foy M.R., Baudry M., Wang J., Finch C.E., Morgan T.E., Pike C.J., Mack W.J., Stanczyk F.Z., Nilsen J. Progesterone receptors: form and function in brain. Front. Neuroendocrinol. 2008, 29:313-339.
9. Brinton R.D., Wang J.M. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent. Curr. Alzheimer Res. 2006, 3:185-190.
10. Caccamo A., Magri A., Oddo S. Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Abeta oligomers accumulation. Mol. Neurodegener. 2010, 5:51.
11. Carroll J.C., Rosario E.R., Chang L., Stanczyk F.Z., Oddo S., LaFerla F.M., Pike C.J. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J. Neurosci. 2007, 27:13357-13365.
12. Carroll J.C., Rosario E.R., Villamagna A., Pike C.J. Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice. Endocrinology 2010, 151:2713-2722.
13. Caruso D., D'Intino G., Giatti S., Maschi O., Pesaresi M., Calabrese D., Garcia-Segura L.M., Calza L., Melcangi R.C. Sex-dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis. J. Neurochem. 2010, 114:921-932.
14. Caruso D., Pesaresi M., Maschi O., Giatti S., Garcia-Segura L.M., Melcangi R.C. Effects of short- and long-term gonadectomy on neuroactive steroid levels in the central and peripheral nervous system of male and female rats. J. Neuroendocrinol. 2010, 22:1137-1147.
15. Caruso D., Scurati S., Maschi O., De Angelis L., Roglio I., Giatti S., Garcia-Segura L.M., Melcangi R.C. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem. Int. 2008, 52:560-568.
16. Chen S., Wang J.M., Irwin R.W., Yao J., Liu L., Brinton R.D. Allopregnanolone promotes regeneration and reduces beta-amyloid burden in a preclinical model of Alzheimer's disease. PLoS One 2011, 6:e24293.
17. Garcia-Segura L.M., Balthazart J. Steroids and neuroprotection: new advances. Front. Neuroendocrinol. 2009, 30. v-ix.
18. Garcia-Segura L.M., Veiga S., Sierra A., Melcangi R.C., Azcoitia I. Aromatase: a neuroprotective enzyme. Prog. Neurobiol. 2003, 71:31-41.
19. Ghosh D., Levault K.R., Barnett A.J., Brewer G.J. A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons. J. Neurosci. 2012, 32:5821-5832.
20. Giatti S., D'Intino G., Maschi O., Pesaresi M., Garcia-Segura L.M., Calza L., Caruso D., Melcangi R.C. Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels. Neurochem. Int. 2010, 56:118-127.
21. Ito D., Imai Y., Ohsawa K., Nakajima K., Fukuuchi Y., Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res. 1998, 57:1-9.
22. Kaufman J.M., Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 2005, 26:833-876.
23. Lanctot K.L., Herrmann N., Rothenburg L., Eryavec G. Behavioral correlates of GABAergic disruption in Alzheimer's disease. Int. Psychogeriatr. 2007, 19:151-158.
24. Luchetti S., Bossers K., Van de Bilt S., Agrapart V., Morales R.R., Frajese G.V., Swaab D.F. Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease. Neurobiol. Aging 2011, 32:1964-1976.
25. Luchetti S., Huitinga I., Swaab D.F. Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience 2011, 191:6-21.
26. Marx C.E., Trost W.T., Shampine L.J., Stevens R.D., Hulette C.M., Steffens D.C., Ervin J.F., Butterfield M.I., Blazer D.G., Massing M.W., Lieberman J.A. The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease. Biol. Psychiatry 2006, 60:1287-1294.
27. Meffre D., Pianos A., Liere P., Eychenne B., Cambourg A., Schumacher M., Stein D.G., Guennoun R. Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. Endocrinology 2007, 148:2505-2517.
28. Melcangi R.C., Caruso D., Levandis G., Abbiati F., Armentero M.T., Blandini F. Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease. J. Mol. Neurosci. 2012, 46:177-183.
29. Melcangi R.C., Garcia-Segura L.M. Sex-specific therapeutic strategies based on neuroactive steroids: in search for innovative tools for neuroprotection. Horm. Behav. 2010, 57:2-11.
30. Melcangi R.C., Garcia-Segura L.M., Mensah-Nyagan A.G. Neuroactive steroids: state of the art and new perspectives. Cell. Mol. Life Sci. 2008, 65:777-797.
31. Middeldorp J., Hol E.M. GFAP in health and disease. Prog. Neurobiol. 2011, 93:421-443.
32. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
33. Olabarria M., Noristani H.N., Verkhratsky A., Rodriguez J.J. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?. Mol. Neurodegener. 2011, 6:55.
34. Overk C.R., Kelley C.M., Mufson E.J. Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2009, 35:415-425.
35. Panzica G.C., Balthazart J., Frye C.A., Garcia-Segura L.M., Herbison A.E., Mensah-Nyagan A.G., McCarthy M.M., Melcangi R.C. Milestones on steroids and the nervous system: 10 years of basic and translational research. J. Neuroendocrinol. 2012, 24:1-15.
36. Pesaresi M., Maschi O., Giatti S., Garcia-Segura L.M., Caruso D., Melcangi R.C. Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm. Behav. 2010, 57:46-55.
37. Rosario E.R., Carroll J., Pike C.J. Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways. Brain Res. 2010, 1359:281-290.
38. Rosario E.R., Carroll J.C., Oddo S., LaFerla F.M., Pike C.J. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J. Neurosci. 2006, 26:13384-13389.
39. Rosario E.R., Chang L., Beckett T.L., Carroll J.C., Paul Murphy M., Stanczyk F.Z., Pike C.J. Age-related changes in serum and brain levels of androgens in male Brown Norway rats. Neuroreport 2009, 20:1534-1537.
40. Rosario E.R., Chang L., Head E.H., Stanczyk F.Z., Pike C.J. Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol. Aging 2011, 32:604-613.
41. Rosario E.R., Chang L., Stanczyk F.Z., Pike C.J. Age-related testosterone depletion and the development of Alzheimer disease. JAMA 2004, 292:1431-1432.
42. Schaeffer V., Meyer L., Patte-Mensah C., Eckert A., Mensah-Nyagan A.G. Dose-dependent and sequence-sensitive effects of amyloid-beta peptide on neurosteroidogenesis in human neuroblastoma cells. Neurochem. Int. 2008, 52:948-955.
43. Schaeffer V., Patte-Mensah C., Eckert A., Mensah-Nyagan A.G. Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins. J. Neurobiol. 2006, 66:868-881.
44. Schaeffer V., Patte-Mensah C., Eckert A., Mensah-Nyagan A.G. Selective regulation of neurosteroid biosynthesis in human neuroblastoma cells under hydrogen peroxide-induced oxidative stress condition. Neuroscience 2008, 151:758-770.
45. Schumacher M., Hussain R., Gago N., Oudinet J.P., Mattern C., Ghoumari A.M. Progesterone synthesis in the nervous system: implications for myelination and myelin repair. Front. Neurosci. 2012, 6:10.
46. Schumacher M., Weill-Engerer S., Liere P., Robert F., Franklin R.J., Garcia-Segura L.M., Lambert J.J., Mayo W., Melcangi R.C., Parducz A., Suter U., Carelli C., Baulieu E.E., Akwa Y. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 2003, 71:3-29.
47. Singh C., Liu L., Wang J.M., Irwin R.W., Yao J., Chen S., Henry S., Thompson R.F., Brinton R.D. Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice. Neurobiol. Aging 2011, 33:1493-1506.
48. Sun C., Ou X., Farley J.M., Stockmeier C., Bigler S., Brinton R.D., Wang J.M. Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease. Curr. Alzheimer Res. 2012, 9:473-480.
49. Wang J.M., Singh C., Liu L., Irwin R.W., Chen S., Chung E.J., Thompson R.F., Brinton R.D. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6498-6503.
50. Wang M., He Y., Eisenman L.N., Fields C., Zeng C.M., Mathews J., Benz A., Fu T., Zorumski E., Steinbach J.H., Covey D.F., Zorumski C.F., Mennerick S. 3beta -hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J. Neurosci. 2002, 22:3366-3375.
51. Weibel E.R. Stereological Methods, vol. 1. Practical Methods for Biological Morphometry 1979, Academic Press, London.
52. Yue X., Lu M., Lancaster T., Cao P., Honda S., Staufenbiel M., Harada N., Zhong Z., Shen Y., Li R. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:19198-19203.